Humacyte, Inc. · NASDAQ:HUMA
Sebelius Kathleen bought 56,818 Humacyte, Inc. shares (Form 4)
Traded May 19, 2026 · Filed May 20, 2026
On May 19, 2026, Sebelius Kathleen (Director) bought 56,818 Humacyte, Inc. shares at US$0.88 for US$50,000, leaving 148,025 shares. Filed May 20, 2026 (Form 4).
- Bought
- 56,818 shares
- Price
- US$0.88
- Value
- US$50,000
- Holding after
- 148,025 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 19, 2026 | Common Stock | Buy | 56,818 | US$0.88 | 148,025 | Direct |
Source
Related
- Humacyte, Inc.
- Sebelius Kathleen
- Humacyte, Inc. shareholders
- Form 4 · Jones Keith Anthony · Sep 15, 2026
- Form 4 · Jones Keith Anthony · Aug 21, 2026
- Form 4 · Jones Keith Anthony · Aug 19, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 28, 2026
- Schedule 13G · Davidson Kempner Capital Management LP · Jun 22, 2026